ArticleExperimental eye research2019

Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189.

Natalie M Guley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.